NCT04196101Phase 2Completed

A Study to Assess EDP-938 for the Treatment of Acute Upper Respiratory Tract Infection With Respiratory Syncytial Virus in Adult Subjects

Study sponsor: Enanta Pharmaceuticals, Inc · ENTA

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2022-01-04Actual
Enrollment · participants82Actual
Source updated2023-10-30Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview